Company Overview and News

 
Hong Kong scraps sale of world’s most expensive land site as market outlook turns cloudy

2018-10-16 scmp
A luxury residential site on The Peak has been withdrawn from sale on Tuesday, a sign that developers are increasingly cautious about the Hong Kong market outlook as a sliding stock market, rising interest rates and the escalating US-China trade war could further dampen buying interest.
SUHJY 0017 0016 SHGKF SHGKY 0083 0012 SUHJF

 
Hong Kong’s tender for a rare land site on The Peak receives ‘unenthusiastic’ response of just five bids

2018-10-12 scmp
A luxury residential site on The Peak has received five bids from property developers, reflecting a cooling appetite for risk as sentiment in the property market continues to soften, amid the fallout of the US-China trade war, rising financing costs and a sharp decline in the stock market, according to one expert.
SUHJY 0017 0016 SHGKF WARFF WARFY SHGKY 0012 SUHJF

 
Hong Kong ranks second in cross-border investments, attracted US$13.26 billion in 12 months until June

2018-10-12 scmp
Hong Kong has moved up 14 places to emerge as the second favourite destination globally for cross-border investment after London, according to an annual report on global commercial real estate investment activity published by Cushman and Wakefield on Thursday.
0012

 
China’s second-tier cities set for rapid house price inflation in coming decade, overshadowing Hong Kong, says DBS

2018-09-26 scmp
Hong Kong’s soaring housing market is beginning to show signs of fatigue, an indication that it is likely to be overtaken by other Chinese cities in terms of price appreciation in the years to come, according to investment bank DBS.
SUHJY 0016 SHGKF SHGKY 0012 SUHJF

 
Chinese real estate services firm E-House seeks up to US$727 million in Hong Kong IPO

2018-09-26 scmp
E-House (China) Enterprise Holdings, one of the country’s biggest real estate services firms, is seeking up to US$727 million in its initial public offering in Hong Kong after delisting from New York two years ago.
C09 CDEVF DTK CDEVY 0012

2
Tycoon Li bets big on property market

2018-08-11 thestar.com.my
HONG KONG: Tycoon Victor Li made his first land purchase in Hong Kong since taking the reins of CK Asset Holdings Ltd from his billionaire father Li Ka-shing, splashing out on a development site above a subway station.
SUHJY 0016 SHGKF UBS SHGKY MTRJY 0012 ULSGF SUHJF

2
Tycoon Victor Li bets big on Hong Kong's frothy property market

2018-08-10 theedgemarkets
HONG KONG (Aug 10): Tycoon Victor Li made his first land purchase in Hong Kong since taking the reins of CK Asset Holdings Ltd from his billionaire father Li Ka-shing, splashing out on a development site above a subway station.
SUHJY 0016 SHGKF UBS SHGKY MTRJY 0012 ULSGF SUHJF

 
5 Reasons to Snap Up CBRE Group (CBRE) Stock Right Away

2018-07-04 zacks
CBRE Group Inc. (CBRE - Free Report) offers a broad range of real estate products and services, and has extensive knowledge of domestic and international real estate markets. The company’s market-leading position will help it to capitalize on commercial real estate tailwinds. In June, the company announced the acquisition of procurement and facilities management solutions provider — FacilitySource, LLC — from Warburg Pincus.
VONOY CBG BLT BHP BHPBF BBL JLL VNNVF BHP BHPLF 0012 CBRE

 
Wong Chuk Hang Station attracts strong interest from property developers, even as new vacancy tax looms

2018-06-27 scmp
Hong Kong property developers have shown keen interest in bidding for a plot of land atop the MTR station in Wong Chuk Hang, even as the government is poised to released its policy position on the proposed vacancy tax, which would encourage companies to clear their stock of completed, but unsold flats.
SUHJY 0016 SHGKF 0129 2007 SHGKY MTRJY 0083 ASASF 0012 SUHJF

 
Home demand helps developers clear housing stock before Hong Kong slaps vacancy tax on hoarders

2018-06-23 scmp
Hong Kong’s property buyers braved a thunderstorm to snap up more than a hundred unoccupied apartment units, helping developers clear the unsold stock ahead of a government plan to impose a so-called vacancy tax to deter hoarding.
SUHJY 0017 0016 SHGKF SHGKY 0012 SUHJF

 
21-year high – Hong Kong property sales expected to touch US$51 billion in first six months this year

2018-06-18 scmp
Property sales in Hong Kong are expected to touch HK$400 billion (US$50.96 billion) – a 21-year high – in the first half this year, as one after another homes, office towers and parking spaces set records in the world’s most expensive real estate market, according to Centaline Property Agency.
SUHJY 0016 SHGKF SHGKY 0012 SUHJF

 
Hong Kong homebuyers snap up flats in city’s first two sales after US interest rate increase

2018-06-16 scmp
Homebuyers in Hong Kong rushed to buy flats on Friday and Saturday in the city’s first two sales after the US raised interest rates, indicating no dip in the buoyant and expensive local property market.
0012

 
Fear of interest rates hike, high prices, hit latest property sale

2018-06-12 scmp
But still, three projects alone have pulled in US$1.46 billion worth of sales released in the past fortnight
0017 0050 0012

 
Hong Kong property giant CK Asset to redevelop Central’s Hutchison House as valuations soar

2018-06-07 scmp
Sources tell the Post the company has served notice on tenants, while analysts estimate the value of the building could triple to some US$3 billion
CKHUF CKHUY 0012

 
Henderson Land looks to farmland conversion, ageing buildings to stoke development pipeline

2018-06-02 scmp
Henderson Land Development will look to a combination of sites sold at government tender and private land acquisitions to help replenish its land bank at a time of soaring property values in Hong Kong.
HDVTY HDVTF 0097 0012

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to HKEX:0012 / Henderson Land Development Co. Ltd on message board site Silicon Investor.

homestead #A001293 homestead #A001293 homestead #A001293 homestead #A001292 homestead #A001292 homestead #A001292
homestead #A001291 homestead #A001291 homestead #A001291 homestead #A001290 homestead #A001290 homestead #A001290
A001295 A001295 A001295 A001294 A001294 A001294